Trump Says 'No Cash' to mRNA, Investors Say 'Bye Bye'
The Trump administration decided to pull the plug on nearly $500 million meant for mRNA vaccine research, leaving biotech investors nervously clutching their wallets. According to reports, the cut "has made investors more hesitant to back biotechs in this space," which is just a polite way of saying they got cold feet. It's like sitting at a promising restaurant table, then watching the host cancel your reservation right before the appetizer. Science funding or lottery? Either way, no surprise funds went "poof."
Share the Story
(1 of 3)Cutting $500M for vaccine research is like closing a lemonade stand right before summer. Genius moves from the admin that make everyone in biotech wanna sell popcorn instead.
Investors gotta be wondering if funding mRNA research feels like betting on a unicorn or a facade. Spoiler: unicorns need money too.
Trump halts mRNA cash flow, biotech investors duck faster than you running from your 8 AM Zoom. Science just got ghosted.
Source: Statnews | Published: 8/14/2025 | Author: Jonathan Wosen and Allison DeAngelis
More Articles in Politics
Sydney Sweeney's $1M Flop, Trump-Approved Jeans & Bathwater Soap Fiasco
Digital Nomad Trapped in Lisbon FOMO, Ends Up BFF Ghosted
Governors Live Rent-Free in Mansions Voters Pay For, Complain About Word 'Mansion'
VP Vance Heads to Pakistan to Broker Peace, Backed by Kushner and Trumpās Threats
Trump Can't Quit NATO But Can Ghost It Like A Toxic Ex
Roger Stone Saves Tulsi From Trumpās Loyalty Laser, Iran Drama Ensues
House Republicans Pretend They Didnāt Hear Democrats Beg For War Limits
